Searched for
OXFORD UNIVERSITY VACCINE
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...
Oxford University to get Poonawala vaccine research facility; to get GBP 50 million fundingSerum Life Sciences is wholly-owned by the Poonawalla family, owners of the Adar Poonawalla-led Serum Institute of India, and the proposed ...
COVID-19 bigger blood clot threat than vaccines, UK study findsThe findings showed although there was an increased risk of having a blood clot after having the first doses of either vaccine, it was much...
AstraZeneca says US trial data shows vaccine 79% effectiveThe U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. The results were announed...
Three month gap between Oxford vaccine jabs provides better efficacy: StudyThe results of the analysis from a phase 3 randomised controlled trial, published in The Lancet journal, suggest that the interval between ...
Britain first country to roll out low cost AstraZeneca and Oxford University vaccineThe Oxford/AstraZeneca vaccine is cheaper and can be stored at fridge temperature, which makes it easier to transport and use. India approv...
Britain approves AstraZeneca/Oxford COVID-19 vaccineRegulatory endorsement is a welcome boost for AstraZeneca and the Oxford team, which have been accused of a lack of clarity about the resul...
After a year-long sprint, coronavirus vaccines are finally at hand, but questions remainThe European Medicines Agency (EMA), charged with overseeing drug approval in the European Union, told AFP that it could approve the first ...
AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum InstituteVaccine major Serum Institute of India on Thursday said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and eff...
Oxford Covid-19 vaccine doing ‘everything expected', independent study findsThe experts say that the novel analysis provides even greater clarity and detail about how the vaccine successfully provokes a strong immun...
Oxford, AstraZeneca COVID-19 vaccine trials resume days after pauseThe study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...
India has fantastic 'vaccine capability'; will be crucial in COVID-19 fight: UK envoy"Clearly India has a fantastic vaccine capability, in particular the Serum Institute. We have entered into a number of agreements and most ...
Double protection: Oxford University COVID-19 vaccine hopes rise with strong trial resultsThe vaccine, named ChAdOx1 nCoV-19, is based on a weakened version of the common cold that causes infections in chimpanzees. It also contai...
AstraZeneca agrees to make COVID-19 vaccine for EuropeAstraZeneca plans to begin delivering the vaccine to European countries by the end of this year under the agreement with the Inclusive Vacc...
Serum Institute to start manufacturing Oxford University's COVID vaccine in 3 weeks; launch by October if trials succeed"Our team has been working closely with Dr Hill from Oxford University, and we are expecting to initiate production of the vaccine in 2-3 w...
Oxford university begins enrolling over 500 volunteers for coronavirus vaccine trialThe researchers, working in an “unprecedented” vaccine development effort to prevent COVID-19, said they have started screening healthy vol...